Anti-Human TGF beta 2 Recombinant Antibody (TAB-100) (CAT#: TAB-100)

Recombinant monoclonal antibody to TGF beta 2. It is a human monoclonal antibody and an immunosuppressive drug developed to reduce scarring after glaucoma drainage surgery.

Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Modalities:
  • Tested Data
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
SDS-PAGE

Figure 1 Anti-TGF beta 2 Antibody (TAB-100) in SDS-PAGE

Figure 1 Anti-TGF beta 2 Antibody (TAB-100) in SDS-PAGE

SDS-PAGE analysis of TAB-100 in non-reduced (lane 1) and β-mercaptoethanol-reduced (lane 2) conditions. Gel stained for 30 minutes with Coomassie Blue. As a result of different β-mercaptoethanol-reduced proteins (Heavy chain and Light chain) migrate as about 50 kDa and 25 kDa, respectively. And non-reduced protein migrates as 130-180 kDa.

SEC-HPLC

Figure 2 Anti-TGF beta 2 Antibody (TAB-100) in HPLC

Figure 2 Anti-TGF beta 2 Antibody (TAB-100) in HPLC

The purity of TAB-100 was greater than 95% as determined by SEC-HPLC.

Column: 3 µm, 7.8x300 nm
Mobile phase: 150 mM Sodium Phosphate Buffer, pH 7.3
Detection: UV280 nm
Injection: 10 µl


Specifications

  • Immunogen
  • An epitope of TGF beta 2 (Human).
  • Host Species
  • Human
  • Derivation
  • Human
  • Type
  • IgG4
  • Specificity
  • Tested positive against native human antigen.
  • Species Reactivity
  • Human
  • Applications
  • ELISA, IP, FC, FuncS, Neut, IF, ICC
  • Related Disease
  • Glaucoma surgery

Product Property

  • Purity
  • >95.0% as determined by analysis by RP-HPLC.
  • Storage
  • Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples.

Applications

  • Application Notes
  • The TGFB2 antibody has been reported in applications of RT-PCR.

Target

  • Alternative Names
  • Lerdelimumab;Trabio;CAT-152;6B1;Anti-TGF-Beta-2;Trabio;Trabio;CAT-152;TGFB2;transforming growth factor, beta 2;transforming growth factor beta-2;G-TSF;cetermin;polyergin;BSC-1 cell growth inhibitor;glioblastoma-derived T-cell suppressor factor;TGF-beta2;M

Related Resources

  • Biosimilar Overview
  • Related Diseases
Please refer to Lerdelimumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Lerdelimumab.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "TGFB2"

Select a product category from the dropdown menu below to view related products.
Please select product type
IgG Antibody Products Neutralizing Antibody Products ScFv Antibody Products Fab Antibody Products ADCC Enhanced Antibody Products

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for TAB-100. Click the button above to contact us or submit your feedback about this product.

Cite This Product

To accurately reference this product in your publication, please use the following citation information:

(Creative Biolabs Cat# TAB-100, RRID: AB_3111804)

Copy citation

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare